7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vision Disorders D014786 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Osteoporosis D010024 12 associated lipids
Kidney Diseases D007674 29 associated lipids
Weight Gain D015430 101 associated lipids
Otosclerosis D010040 2 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Calcinosis D002114 5 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Lee HJ et al. Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. 2014 Menopause pmid:23760429
Guo L et al. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. 2014 DNA Cell Biol. pmid:24283361
Samara S et al. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. 2014 Exp. Mol. Pathol. pmid:24200492
Bastos MF et al. Effects of Cachaça, a typical Brazilian alcoholic beverage, on alveolar bone loss and density: a study in peripubertal rats. 2014 Arch. Oral Biol. pmid:24183604
Park K et al. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation. 2014 Int. J. Mol. Med. pmid:24248634
Casarin RC et al. Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. 2014 Int J Oral Maxillofac Surg pmid:24530035
Puato M et al. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. 2014 J Hum Hypertens pmid:23842084
Ma Y et al. Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors. 2014 Mol. Cell. Endocrinol. pmid:24508663
Wu H et al. Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis rats. 2014 Immunopharmacol Immunotoxicol pmid:24450920
Titanji K et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. 2014 PLoS Pathog. pmid:25393853
Akiyama N et al. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. 2014 J. Exp. Med. pmid:25385757
Lv Y et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. 2014 BMC Musculoskelet Disord pmid:25377946
D'Abramo A et al. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. 2014 Mediators Inflamm. pmid:25374442
Samir SM and Malek HA Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. 2014 J. Physiol. Pharmacol. pmid:25371528
Arrigoni C et al. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. 2014 Mol. Cancer pmid:25335447
Cardelli M and Aubin JE ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. 2014 PLoS ONE pmid:25313644
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Movérare-Skrtic S et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. 2014 Nat. Med. pmid:25306233
Holt V et al. Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. 2014 PLoS ONE pmid:25302610
Moran CS et al. Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. 2014 Arterioscler. Thromb. Vasc. Biol. pmid:25301844
Hayashida C et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. 2014 J. Biol. Chem. pmid:24610813
Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. 2014 J. Vasc. Res. pmid:24642764
Wohlfahrt JC et al. Sulcus fluid bone marker levels and the outcome of surgical treatment of peri-implantitis. 2014 J. Clin. Periodontol. pmid:24417563
Park SY et al. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. 2014 Toxicol. Appl. Pharmacol. pmid:24463094
Wang B et al. Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model. 2014 pmid:24431282
Yokota K et al. Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. 2014 pmid:24431283
Foo JP et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. 2014 J. Clin. Endocrinol. Metab. pmid:25148234
Warren JT et al. Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. 2014 Sci Signal pmid:25140055
Yan D et al. Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. 2014 J Orthop Surg Res pmid:25138985
Schieferdecker A et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. 2014 Oncotarget pmid:25138051
Chung SL et al. Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. 2014 J. Orthop. Res. pmid:25131218
Yoshida S et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. 2014 PLoS ONE pmid:25105978
Li T et al. Rabbiteye blueberry prevents osteoporosis in ovariectomized rats. 2014 J Orthop Surg Res pmid:25102951
Kwan JS et al. Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels. 2014 Hum. Mol. Genet. pmid:25080503
Yang X et al. [Preliminary study on the best-exerted force chance in the female menstrual cycle]. 2014 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:25033640
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
Loureiro MB et al. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. 2014 Diabetes Res. Clin. Pract. pmid:24529565
Tera Tde M et al. The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. 2014 Braz Oral Res pmid:25229791
Huang C et al. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. 2014 Biomed Mater pmid:24518283
Izawa A et al. Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice. 2014 Infect. Immun. pmid:24566623
Todenhöfer T et al. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. 2014 BJU Int. pmid:23360112
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
Sirjani M et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. 2014 Iran J Allergy Asthma Immunol pmid:24659160
Wang JH et al. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. 2014 J Clin Hypertens (Greenwich) pmid:24640954
Liu YP et al. Association of the g.27563G>A osteoprotegerin genetic polymorphism with bone mineral density in Chinese women. 2014 Genet. Mol. Res. pmid:24615112
Ovchinnikova OA et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. 2014 J. Intern. Med. pmid:24588843
Montes de Oca A et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. 2014 PLoS ONE pmid:24586847
Ostrowska Z et al. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa. 2014 Endokrynol Pol pmid:24549600
Rachner TD et al. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. 2014 Breast Cancer Res. pmid:24528599

Table of Content